These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1983899)

  • 1. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State.
    Karagas MR; Thomas DB; Roth GJ; Johnson LK; Weiss NS
    Am J Epidemiol; 1991 Jan; 133(1):58-62. PubMed ID: 1983899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994.
    Merlino LA; Sullivan KJ; Whitaker DC; Lynch CF
    J Am Acad Dermatol; 1997 Oct; 37(4):578-85. PubMed ID: 9344197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous melanoma following cervical intra-epithelial neoplasia in western Washington State.
    Shmulewitz EY; Weiss NS; Schwartz SM
    Cancer Causes Control; 1993 May; 4(3):225-9. PubMed ID: 8318639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures.
    Koh HK; Clapp RW; Barnett JM; Nannery WM; Tahan SR; Geller AC; Bhawan J; Harrist TJ; Kwan T; Stadecker M
    J Am Acad Dermatol; 1991 Apr; 24(4):545-50. PubMed ID: 2033127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive capture of cutaneous melanoma by the Ontario Cancer Registry: validation study using community pathology reports.
    Tran JM; Schwartz R; Fung K; Rochon P; Chan AW
    Cancer Causes Control; 2016 Jan; 27(1):137-42. PubMed ID: 26537120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What increased registry outreach may mean for cutaneous melanoma surveillance: impact of changes in Iowa.
    Charlton ME; Sapkota K; Eide MJ; Olson DB; McKeen K; Platz CE; Schlichting JA; Lynch CF
    J Registry Manag; 2014; 41(4):201-8. PubMed ID: 25803634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration and melanoma incidence rates among Washington state counties.
    Chan V; Thompson I; Whitney D; Switzer M; Anderson AD; Smits S
    Melanoma Res; 2013 Aug; 23(4):312-20. PubMed ID: 23598365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].
    Lehnert M; Eberle A; Hentschel S; Katalinic A; Kieschke J; Schmidtmann I; Schubert-Fritschle G; Stegmaier C; Hense HW
    Gesundheitswesen; 2005 Oct; 67(10):729-35. PubMed ID: 16235142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma risk by age and socio-economic status.
    Kirkpatrick CS; Lee JA; White E
    Int J Cancer; 1990 Jul; 46(1):1-4. PubMed ID: 2365492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with registration of cutaneous malignant melanoma in England.
    Melia J; Frost T; Graham-Brown R; Hunter J; Marsden A; du Vivier A; Warin AP; White J; Whitehead S; Wroughton M
    Br J Cancer; 1995 Jul; 72(1):224-8. PubMed ID: 7599057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic evaluation of pigmented lesions in Connecticut and its influence on the reporting of melanoma.
    Bolognia JL; Headley A; Fine J; Berwick M
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):198-202. PubMed ID: 1552053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.
    Nevins T; Su Y; Doucette S; Kanigsberg N
    J Cutan Med Surg; 2008; 12(6):276-81. PubMed ID: 19317949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cutaneous melanoma in Germany and worldwide.
    Garbe C; Blum A
    Skin Pharmacol Appl Skin Physiol; 2001; 14(5):280-90. PubMed ID: 11586069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How complete has skin cancer registration been in the UK? A study from Yorkshire.
    Stefoski Mikeljevic J; Johnston C; Adamson PJ; Wright A; Bishop JA; Batman P; Neal RD; Forman D
    Eur J Cancer Prev; 2003 Apr; 12(2):125-33. PubMed ID: 12671536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging epidemic of melanoma and squamous cell skin cancer.
    Glass AG; Hoover RN
    JAMA; 1989 Oct; 262(15):2097-100. PubMed ID: 2795783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of malignant melanoma--lessons to be learned from Austria.
    Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
    Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
    Karlsson PM; Fredrikson M
    Int J Cancer; 2007 Jul; 121(2):323-8. PubMed ID: 17372908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.